The Enterprise Value as of December 2025 (TTM) for Ascentage Pharma Group International (ASPHF) is 21.50B

According to Ascentage Pharma Group International’s latest financial reports and current stock price. The company's current Enterprise Value is 21.50B. This represents a change of 61.77% compared to the average of 13.29B of the last 4 quarters.

Ascentage Pharma Group International (ASPHF) Historical Enterprise Value (quarterly & annually)

How has ASPHF Enterprise Value performed in the past?

The mean historical Enterprise Value of Ascentage Pharma Group International over the last ten years is 6.72B. The current 21.50B Enterprise Value has changed 31.90% with respect to the historical average. Over the past ten years (40 quarters), ASPHF's Enterprise Value was at its highest in in the June 2025 quarter at 23.88B. The Enterprise Value was at its lowest in in the January 2016 quarter at 0.

Ascentage Pharma Group International (ASPHF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Ascentage Pharma Group International Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ascentage Pharma Group International (ASPHF) Average Enterprise Value

How has ASPHF Enterprise Value performed in the past?

The current Enterprise Value of Ascentage Pharma Group International (ASPHF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Ascentage Pharma Group International (ASPHF) Enterprise Value vs. Peers

How is ASPHF’s Enterprise Value compared to its peers?

Ascentage Pharma Group International’s Enterprise Value is greater than MorphoSys AG (2.93B), less than Takara Bio Inc. (82.75B), greater than Galenica AG (5.37B), greater than Indivior PLC (3.93B), less than Sugi Holdings Co.,Ltd. (606.93B), greater than Ascentage Pharma Group International (20.23B), greater than Indivior PLC (3.93B), less than Mediclinic International plc (392.32B), greater than Biotest AG (2.02B), greater than Abcam plc (134.60M),

Build a custom stock screener for Ascentage Pharma Group International (ASPHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ascentage Pharma Group International using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ascentage Pharma Group International (ASPHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ascentage Pharma Group International or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.